Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Pharmacokinetics of Clindamycin in Obese and Nonobese Children.

Smith MJ, Gonzalez D, Goldman JL, Yogev R, Sullivan JE, Reed MD, Anand R, Martz K, Berezny K, Benjamin DK Jr, Smith PB, Cohen-Wolkowiez M, Watt K; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02014-16. doi: 10.1128/AAC.02014-16. Print 2017 Apr.

2.

Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.

England A, Wade K, Smith PB, Berezny K, Laughon M; Best Pharmaceuticals for Children Act — Pediatric Trials Network Administrative Core Committee.

Contemp Clin Trials. 2016 Mar;47:376-82. doi: 10.1016/j.cct.2016.03.002. Epub 2016 Mar 9.

3.

Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.

Benjamin DK Jr, Hudak ML, Duara S, Randolph DA, Bidegain M, Mundakel GT, Natarajan G, Burchfield DJ, White RD, Shattuck KE, Neu N, Bendel CM, Kim MR, Finer NN, Stewart DL, Arrieta AC, Wade KC, Kaufman DA, Manzoni P, Prather KO, Testoni D, Berezny KY, Smith PB; Fluconazole Prophylaxis Study Team.

JAMA. 2014 May 7;311(17):1742-9. doi: 10.1001/jama.2014.2624.

4.

Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.

Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Rich W, Brozanski BS, van den Anker J, Blumer J, Laughon M, Watt KM, Kearns GL, Capparelli EV, Martz K, Berezny K, Benjamin DK Jr, Smith PB; Meropenem Study Team.

Clin Infect Dis. 2012 Dec;55(11):1495-502. doi: 10.1093/cid/cis758. Epub 2012 Sep 5.

5.

Innovative clinical trial design for pediatric therapeutics.

Laughon MM, Benjamin DK Jr, Capparelli EV, Kearns GL, Berezny K, Paul IM, Wade K, Barrett J, Smith PB, Cohen-Wolkowiez M.

Expert Rev Clin Pharmacol. 2011 Sep;4(5):643-52. doi: 10.1586/ecp.11.43. Review.

6.

Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial.

Li JS, Yow E, Berezny KY, Bokesch PM, Takahashi M, Graham TP Jr, Sanders SP, Sidi D, Bonnet D, Ewert P, Jennings LK, Michelson AD; PICOLO Investigators.

Circulation. 2008 Jan 29;117(4):553-9. doi: 10.1161/CIRCULATIONAHA.107.715821. Epub 2008 Jan 14.

PMID:
18195173
7.

Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?

Li JS, Yow E, Berezny KY, Rhodes JF, Bokesch PM, Charpie JR, Forbus GA, Mahony L, Boshkov L, Lambert V, Bonnet D, Michel-Behnke I, Graham TP, Takahashi M, Jaggers J, Califf RM, Rakhit A, Fontecave S, Sanders SP.

Circulation. 2007 Jul 17;116(3):293-7. Epub 2007 Jun 25.

PMID:
17592082
8.

Racial differences are seen in blood pressure response to fosinopril in hypertensive children.

Menon S, Berezny KY, Kilaru R, Benjamin DK Jr, Kay JD, Hazan L, Portman R, Hogg R, Deitchman D, Califf RM, Li JS.

Am Heart J. 2006 Aug;152(2):394-9.

PMID:
16875928
9.

Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?

Li JS, Berezny K, Kilaru R, Hazan L, Portman R, Hogg R, Jenkins RD, Kanani P, Cottrill CM, Mattoo TK, Zharkova L, Kozlova L, Weisman I, Deitchman D, Califf RM.

Hypertension. 2004 Sep;44(3):289-93. Epub 2004 Jul 19.

PMID:
15262902

Supplemental Content

Loading ...
Support Center